AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Jul 2001 11:00 AM
RNS
Interim Results - Part 1 of 2
25 Jul 2001 04:00 PM
RNS
Appointment of Dr Jane Henney
25 Jul 2001 09:00 AM
RNS
Notice of Results
03 Jul 2001 10:00 AM
RNS
Holding in Company
02 Jul 2001 12:01 PM
RNS
Holding in Company
28 Jun 2001 07:00 AM
RNS
Purchase of Own Securities
27 Jun 2001 01:30 PM
RNS
Regulatory Application
13 Jun 2001 04:00 PM
RNS
Holding in Company
01 Jun 2001 07:00 AM
RNS
Purchase of Own Securities
23 May 2001 04:00 PM
RNS
Holding in Company
17 May 2001 07:00 AM
RNS
Purchase of Own Securities
09 May 2001 07:00 AM
RNS
Purchase of Own Securities
08 May 2001 07:00 AM
RNS
Purchase of Own Securities
04 May 2001 07:00 AM
RNS
Purchase of Own Securities
03 May 2001 07:00 AM
RNS
Purchase of Own Securities
02 May 2001 04:45 PM
RNS
Re Prilosec Patent
02 May 2001 03:45 PM
RNS
Research Update
02 May 2001 07:00 AM
RNS
Purchase of Own Securities
27 Apr 2001 11:21 AM
RNS
Result of AGM
26 Apr 2001 09:30 AM
RNS
Q1 Results - Part 2 of 2
26 Apr 2001 09:30 AM
RNS
Q1 Results - Part 1 of 2
25 Apr 2001 09:00 AM
RNS
Notice of Results
23 Apr 2001 09:17 AM
RNS
Stmnt re Lawsuit
30 Mar 2001 04:30 PM
RNS
Director Shareholding
30 Mar 2001 07:30 AM
RNS
Regulatory Application
26 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
15 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
14 Mar 2001 07:00 AM
RNS
Share RePurchase
09 Mar 2001 03:14 PM
RNS
Re Annual Report, etc.
09 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
07 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
01 Mar 2001 07:01 AM
RNS
Purchase of Own Securities
27 Feb 2001 07:01 AM
RNS
Purchase of Own Securities
26 Feb 2001 04:00 PM
RNS
Holding in Company
22 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
21 Feb 2001 07:01 AM
RNS
Regulatory Approval
20 Feb 2001 06:23 PM
RNS
Dividend
20 Feb 2001 09:00 AM
RNS
Patent Court Ruling Upheld
12 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
09 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
08 Feb 2001 07:07 AM
RNS
Dividend
08 Feb 2001 07:01 AM
RNS
Final Results Part 2 of 2
08 Feb 2001 07:01 AM
RNS
Final Results Part 1 of 2
07 Feb 2001 04:00 PM
RNS
Holding in Company
07 Feb 2001 09:00 AM
RNS
Notice of Results
06 Feb 2001 05:00 PM
RNS
Director Shareholding
01 Feb 2001 12:52 PM
RNS
Re Agreement
19 Jan 2001 01:30 PM
RNS
Disposal
09 Jan 2001 09:13 AM
RNS
Stmnt re Genpharm Inc
04 Jan 2001 10:00 AM
RNS
Stmnt re MRP Approval

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings